Manage Your Liver
Q:

Liver Fibrosis: Avoiding and preventing the worsening of liver inflammation is the key!

Liver Fibrosis: Avoiding and preventing the worsening of liver inflammation is the key!
A:

Liver fibrosis is a condition that occurs in many chronic liver diseases. It is usually caused by long term inflammation and damage to liver cells. Some of the common causes of liver inflammation are: Chronic hepatitis B/C, fatty liver disease, alcohol abuse, drug toxicity liver damage, etc. Liver fibrosis can be classified into five different levels, denoted as: F0, F1, F2, F3 and F4. F0 means that the liver cells are normal with no fibrotic tissues; a higher number indicates a higher level of fibrosis of the liver, with F4 representing cirrhosis. [1]

 

In Western medicine, liver fibrosis is a consequence of long-term damage to liver cells, it is thought to be a passive and irreversible process. At present, there is no medicine that can directly treat liver fibrosis or cirrhosis. Also, as the fibrotic tissues and damaged liver cells are usually distributed throughout the liver, it is not possible to remove the affected parts of the liver by surgery. 

 

Due to the lack of treatment options, doctors generally recommend patients to improve their lifestyle, or to treat the cause (e.g. chronic hepatitis, fatty liver, NASH) of liver fibrosis, in hopes of slowing down the progression and the worsening of the condition. [2]

 

If liver fibrosis is developed, chronic liver disease patients should be very alert and think twice about treatments they receive, as during the treatment process, the drugs may further damage liver cells and affect liver function due to the toxicity of the drug itself. Therefore, patients with chronic liver disease should focus mainly on stopping inflammation in the liver (by lowering ALT level) and preventing fibrosis. This is the only way to reduce the complications of treatment. 

 

It is important that patients understand that drug treatments can sometimes cause further damage to liver cells, and that they should not take excessive medications; rather they should choose an appropriate and safe means of prevention or treatment.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
A:
With thousands of supplements in the market, and little regulations on supplements, finding a suitable one is difficult enough, let alone finding a SAFE one!   Here we will look at 5 things that you can look for when buying or using supplements, it can help you to avoid risky products and limited the chance of using something unsafe:   1. Look for registrations In some country, there are registration systems on suppl
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us